Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Stefano Mastrangelo, Alberto Romano, Giorgio Attinà, Palma Maurizi, Antonio Ruggiero
Functional assay for assessment of agonistic or antagonistic activity of angiotensin AT<sub>2</sub> receptor ligands reveals that EMA401 and PD123319 have agonistic properties
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): A. Augusto Peluso, Igor M. Souza-Silva, Daniel C. Villela, Pernille B.L. Hansen, Anders Hallberg, Michael Bader, Robson Santos, Colin Sumners, U. Muscha Steckelings
Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Aeshah Alluli, Willem Rijnbout St. James, David H. Eidelman, Carolyn J. Baglole
The effects of environmental aryl hydrocarbon receptor ligands on signaling and cell metabolism in cancer
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Sean A. Piwarski, Travis B. Salisbury
Mechanisms of breast cancer progression induced by environment-polluting aryl hydrocarbon receptor agonists
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Noelia V. Miret, Carolina A. Pontillo, Sol Buján, Florencia A. Chiappini, Andrea S. Randi
Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C.D. Medeiros, Elliot Ensink, Karen T. Liby, Elizabeth A. Wellberg, Sophia Y. Lunt, Jamie J. Bernard
Lung cancer associated with combustion particles and fine particulate matter (PM<sub>2.5</sub>) – The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Jørn A. Holme, Jan Vondráček, Miroslav Machala, Dominique Lagadic-Gossmann, Christoph F.A. Vogel, Eric Le Ferrec, Lydie Sparfel, Johan Øvrevik
Aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR) play both distinct and common roles in the regulation of colon homeostasis and intestinal carcinogenesis
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Gerardo Vázquez-Gómez, Jiří Petráš, Zdeněk Dvořák, Jan Vondráček
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Christiane A. Opitz, Pauline Holfelder, Mirja Tamara Prentzell, Saskia Trump
Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders
Publication date: October 2023
Source: Biochemical Pharmacology, Volume 216
Author(s): Stefano Fiorucci, Valentina Sepe, Michele Biagioli, Bianca Fiorillo, Pasquale Rapacciuolo, Eleonora Distrutti, Angela Zampella